35 related articles for article (PubMed ID: 25968875)
1. HMGA2-induced epithelial-mesenchymal transition is reversed by let-7d in intrauterine adhesions.
Song M; Cao C; Zhou Z; Yao S; Jiang P; Wang H; Zhao G; Hu Y
Mol Hum Reprod; 2021 Feb; 27(2):. PubMed ID: 33237328
[TBL] [Abstract][Full Text] [Related]
2. Expression of E-cadherin repressors SNAIL, ZEB1 and ZEB2 by tumour and stromal cells influences tumour-budding phenotype and suggests heterogeneity of stromal cells in pancreatic cancer.
Galván JA; Zlobec I; Wartenberg M; Lugli A; Gloor B; Perren A; Karamitopoulou E
Br J Cancer; 2015 Jun; 112(12):1944-50. PubMed ID: 25989272
[TBL] [Abstract][Full Text] [Related]
3. Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update.
Gurzu S; Turdean S; Kovecsi A; Contac AO; Jung I
World J Clin Cases; 2015 May; 3(5):393-404. PubMed ID: 25984514
[TBL] [Abstract][Full Text] [Related]
4. Gli1 promotes transforming growth factor-beta1- and epidermal growth factor-induced epithelial to mesenchymal transition in pancreatic cancer cells.
Liu Q; Sheng W; Dong M; Dong X; Dong Q; Li F
Surgery; 2015 Jul; 158(1):211-24. PubMed ID: 25979438
[TBL] [Abstract][Full Text] [Related]
5. HMGA2 promotes cancer metastasis by regulating epithelial-mesenchymal transition.
Ma Q; Ye S; Liu H; Zhao Y; Mao Y; Zhang W
Front Oncol; 2024; 14():1320887. PubMed ID: 38361784
[TBL] [Abstract][Full Text] [Related]
6. HMGA2 as a Critical Regulator in Cancer Development.
Mansoori B; Mohammadi A; Ditzel HJ; Duijf PHG; Khaze V; Gjerstorff MF; Baradaran B
Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33668453
[TBL] [Abstract][Full Text] [Related]
7. Honokiol Suppressed Pancreatic Cancer Progression via miR-101/Mcl-1 Axis.
Wang Y; Liu Z; Liu Q; Han Y; Zang Y; Zhang H; Du X; Qin T; Wu Y
Cancer Manag Res; 2020; 12():5243-5254. PubMed ID: 32669873
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microRNAs in pancreatic cancer: a meta-analysis.
Zhao F; Wei C; Cui MY; Xia QQ; Wang SB; Zhang Y
Aging (Albany NY); 2020 May; 12(10):9380-9404. PubMed ID: 32420903
[TBL] [Abstract][Full Text] [Related]
9. High Mobility Group A (HMGA): Chromatin Nodes Controlled by a Knotty miRNA Network.
Sgarra R; Pegoraro S; D'Angelo D; Ros G; Zanin R; Sgubin M; Petrosino S; Battista S; Manfioletti G
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979076
[TBL] [Abstract][Full Text] [Related]
10. MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44.
Li L; Shao MY; Zou SC; Xiao ZF; Chen ZC
J Neurooncol; 2019 Jan; 141(1):19-30. PubMed ID: 30539341
[TBL] [Abstract][Full Text] [Related]
11. Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance.
Chiou SH; Dorsch M; Kusch E; Naranjo S; Kozak MM; Koong AC; Winslow MM; Grüner BM
Sci Rep; 2018 Sep; 8(1):14008. PubMed ID: 30228296
[TBL] [Abstract][Full Text] [Related]
12. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.
Hiramoto H; Muramatsu T; Ichikawa D; Tanimoto K; Yasukawa S; Otsuji E; Inazawa J
Sci Rep; 2017 Jun; 7(1):4002. PubMed ID: 28638102
[TBL] [Abstract][Full Text] [Related]
13. Predicting MicroRNA Biomarkers for Cancer Using Phylogenetic Tree and Microarray Analysis.
Wang H
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27213352
[TBL] [Abstract][Full Text] [Related]
14. The transcriptional modulator HMGA2 promotes stemness and tumorigenicity in glioblastoma.
Kaur H; Ali SZ; Huey L; Hütt-Cabezas M; Taylor I; Mao XG; Weingart M; Chu Q; Rodriguez FJ; Eberhart CG; Raabe EH
Cancer Lett; 2016 Jul; 377(1):55-64. PubMed ID: 27102002
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.
Taucher V; Mangge H; Haybaeck J
Cell Oncol (Dordr); 2016 Aug; 39(4):295-318. PubMed ID: 27060060
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.
Liu N; Xia WY; Liu SS; Chen HY; Sun L; Liu MY; Li LF; Lu HM; Fu YJ; Wang P; Wu H; Gao JX
Sci Rep; 2016 Feb; 6():20489. PubMed ID: 26841847
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.
Shao Y; Li P; Zhu ST; Yue JP; Ji XJ; He Z; Ma D; Wang L; Wang YJ; Zong Y; Wu YD; Zhang ST
PLoS One; 2015; 10(11):e0140642. PubMed ID: 26556718
[TBL] [Abstract][Full Text] [Related]
18. miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells.
Jiang W; Gu W; Qiu R; He S; Shen C; Wu Y; Zhang J; Zhou J; Guo Y; Wan D; Li Z; Deng J; Zeng L; Tang J; Zhou J; Zhi Q; Deng X
Anticancer Agents Med Chem; 2016; 16(4):432-9. PubMed ID: 25968875
[TBL] [Abstract][Full Text] [Related]
19. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
